M

MaineHealth Maine Medical Center | Maine Children's Cancer Program

Research site

(Unclaimed)

Location

100 Campus Drive Suite 107, Scarborough, Maine, United States of America

Site insights

Top conditions

Top treatments

Cyclophosphamide

Etoposide

cyclophosphamide

Vincristine Sulfate

Carboplatin

Vincristine

Doxorubicin Hydrochloride

vincristine sulfate

Cisplatin

Methotrexate

Parent organization

This site is a part of MaineHealth Maine Medical Center

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 121 total trials

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or me...

Enrolling

Locally Advanced Solid Tumors

Primary CNS Tumors

Drug: Oral repotrectinib (TPX-0005)

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherapy regimen...

Enrolling

Hodgkin Lymphoma

Drug: Etoposide

Drug: DTIC

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling

Multiple Myeloma

Advanced Solid Tumors

Drug: Trastuzumab and Pertuzumab

Drug: Palbociclib